DD276165A5 - Verfahren zur detektion maligner zellen - Google Patents

Verfahren zur detektion maligner zellen Download PDF

Info

Publication number
DD276165A5
DD276165A5 DD87322420A DD32242087A DD276165A5 DD 276165 A5 DD276165 A5 DD 276165A5 DD 87322420 A DD87322420 A DD 87322420A DD 32242087 A DD32242087 A DD 32242087A DD 276165 A5 DD276165 A5 DD 276165A5
Authority
DD
German Democratic Republic
Prior art keywords
cells
antibody
human
antigen
antibodies
Prior art date
Application number
DD87322420A
Other languages
German (de)
English (en)
Inventor
Karl E Hellstrom
Joseph P Brown
Ingegerd Hellstrom
Hans Marquardt
Original Assignee
K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by K filed Critical K
Publication of DD276165A5 publication Critical patent/DD276165A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DD87322420A 1986-02-26 1987-02-25 Verfahren zur detektion maligner zellen DD276165A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/834,172 US5185432A (en) 1986-02-26 1986-02-26 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas

Publications (1)

Publication Number Publication Date
DD276165A5 true DD276165A5 (de) 1990-02-14

Family

ID=25266276

Family Applications (2)

Application Number Title Priority Date Filing Date
DD87322420A DD276165A5 (de) 1986-02-26 1987-02-25 Verfahren zur detektion maligner zellen
DD30018987A DD266028A5 (de) 1986-02-26 1987-02-25 Verfahren zur herstellung eines monoklonalen antikörpers

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD30018987A DD266028A5 (de) 1986-02-26 1987-02-25 Verfahren zur herstellung eines monoklonalen antikörpers

Country Status (28)

Country Link
US (1) US5185432A (fr)
JP (1) JPS62220197A (fr)
KR (2) KR870008026A (fr)
CN (1) CN87100927A (fr)
AT (1) AT400577B (fr)
AU (1) AU612967B2 (fr)
BE (1) BE1000611A5 (fr)
CA (1) CA1312025C (fr)
CH (1) CH675880A5 (fr)
DD (2) DD276165A5 (fr)
DE (1) DE3705276A1 (fr)
DK (1) DK98187A (fr)
ES (1) ES2004245A6 (fr)
FI (1) FI870764A7 (fr)
FR (1) FR2596062B1 (fr)
GB (1) GB2186885B (fr)
GR (1) GR870294B (fr)
IE (1) IE60286B1 (fr)
IT (1) IT1203511B (fr)
LU (1) LU86786A1 (fr)
NL (1) NL8700415A (fr)
NO (1) NO174719C (fr)
NZ (1) NZ219338A (fr)
OA (1) OA08485A (fr)
PT (1) PT84370B (fr)
SE (2) SE467988B (fr)
YU (1) YU46189B (fr)
ZA (1) ZA869494B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531301A1 (de) * 1985-09-02 1987-03-05 Behringwerke Ag Monoklonale antikoerper gegen tumorassoziierte glykoproteine, verfahren zu ihrer herstellung sowie ihre verwendung
JPH0813840B2 (ja) * 1987-03-31 1996-02-14 協和醗酵工業株式会社 抗ヒト肺腺癌単クロ−ン性抗体
US5134075A (en) * 1989-02-17 1992-07-28 Oncogen Limited Partnership Monoclonal antibody to novel antigen associated with human tumors
US5171665A (en) * 1989-04-17 1992-12-15 Oncogen Monoclonal antibody to novel antigen associated with human tumors
US5342774A (en) * 1991-05-23 1994-08-30 Ludwig Institute For Cancer Research Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
DE69831522T2 (de) 1997-03-03 2006-06-14 Amersham Biosciences Uk Ltd In-situ Zellextraktion und Assay-Verfahren
DE19725133A1 (de) * 1997-06-13 1998-12-17 Micromet Ges Fuer Biomedizinis Nachweis von seltenen Zellen
US20050089918A1 (en) * 1998-02-23 2005-04-28 Amersham Biosciences Uk Limited In-situ cell extraction and assay method
US6117981A (en) * 1999-06-03 2000-09-12 Cytoclonal Pharmaceutics, Inc. Hybridomas for lung cancer marker and monoclonal antibodies thereof
JP2003512819A (ja) * 1999-09-03 2003-04-08 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド Ｂ７様ポリヌクレオチド、ポリペプチドおよび抗体
US6965018B2 (en) 2000-06-06 2005-11-15 Bristol-Myers Squibb Company Antibodies directed to B7-related polypeptide, BSL-2
TWI317285B (en) * 2000-07-28 2009-11-21 Dainippon Sumitomo Pharma Co New use and kit for remedies for cancer
CN101724072B (zh) * 2008-10-27 2013-10-09 谷为岳 一种抗肿瘤的单克隆抗体的序列及应用
GB0916686D0 (en) * 2009-09-23 2009-11-04 Univ Manchester Metropolitan Treatment of cancer
PH12012501751A1 (en) 2010-03-04 2012-11-12 Macrogenics Inc Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
DK2542256T3 (da) 2010-03-04 2019-08-26 Macrogenics Inc Antistoffer reagerende med b7-h3, immunologisk aktive fragmenter deraf og anvendelser deraf
WO2012036094A1 (fr) * 2010-09-17 2012-03-22 独立行政法人産業技術総合研究所 Marqueur d'identification du cancer du poumon
CN102391992B (zh) * 2011-11-03 2012-08-29 潘世扬 抗人非小细胞肺癌单克隆抗体及其应用
CN109069633A (zh) 2016-04-15 2018-12-21 宏观基因有限公司 新颖的b7-h3-结合分子、其抗体药物缀合物及其使用方法
CN111662371B (zh) * 2020-04-30 2023-07-04 美康生物科技股份有限公司 细胞角蛋白19片段抗原及其制备方法和应用
CN112300284B (zh) * 2020-12-29 2021-04-06 慈达(广州)生物技术有限公司 核酸筛选结合抗体检测用于癌症检测中的用途及其制备的试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569788A (en) * 1983-05-18 1986-02-11 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies against non small cell lung cancer
IL76877A (en) * 1984-11-02 1991-11-21 Oncogen Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies
ZA858371B (en) * 1984-11-02 1987-03-25 Oncogen Monoclonal antibodies for human non-small cell lung carcinomas

Also Published As

Publication number Publication date
ES2004245A6 (es) 1988-12-16
BE1000611A5 (fr) 1989-02-21
YU25787A (en) 1990-12-31
DE3705276A1 (de) 1987-08-27
KR870008026A (ko) 1987-09-23
YU46189B (sh) 1993-05-28
IT8719491A0 (it) 1987-02-25
GR870294B (en) 1987-06-30
PT84370A (en) 1987-03-01
NL8700415A (nl) 1987-09-16
KR880010438A (ko) 1988-10-08
LU86786A1 (fr) 1987-09-15
IE60286B1 (en) 1994-06-29
FI870764A0 (fi) 1987-02-23
ZA869494B (en) 1987-10-28
JPS62220197A (ja) 1987-09-28
PT84370B (pt) 1989-11-10
OA08485A (fr) 1988-07-29
NO174719B (no) 1994-03-14
GB8703700D0 (en) 1987-03-25
DK98187A (da) 1987-08-27
CH675880A5 (fr) 1990-11-15
ATA43587A (de) 1995-06-15
NO174719C (no) 1994-06-22
US5185432A (en) 1993-02-09
NO870770D0 (no) 1987-02-25
CN87100927A (zh) 1988-10-05
GB2186885B (en) 1990-10-03
DK98187D0 (da) 1987-02-25
SE9201529A0 (sv) 1992-05-14
SE9201529D0 (sv) 1992-05-14
SE8700805D0 (sv) 1987-02-25
KR900006338B1 (ko) 1990-08-28
AU612967B2 (en) 1991-07-25
CA1312025C (fr) 1992-12-29
SE467988B (sv) 1992-10-12
FI870764A7 (fi) 1987-08-27
SE8700805L (sv) 1987-10-22
AT400577B (de) 1996-01-25
NO870770L (no) 1987-08-27
AU6927287A (en) 1987-08-27
IT1203511B (it) 1989-02-15
FR2596062B1 (fr) 1990-06-08
DD266028A5 (de) 1989-03-22
NZ219338A (en) 1991-11-26
GB2186885A (en) 1987-08-26
FR2596062A1 (fr) 1987-09-25
IE870487L (en) 1987-08-26

Similar Documents

Publication Publication Date Title
DE3751585T2 (de) Hybridome, die monoklonale Antikörper gegen neue Mucin-Epitope produzieren.
AT400577B (de) Verfahren zur herstellung eines monoklonalen antikörpers und verfahren zum nachweisen von malignen zellen
DE3586262T2 (de) Monoklonale antikoerper und antigen fuer menschliche lungenkarzinome vom nichtkleinen zellentyp.
DE3687736T2 (de) Monoklonale antikoerper gegen humanen brustkrebs, korrespondierende hybridome, deren herstellung und verwendung.
DE68922385T2 (de) Neuer monoklonaler Antikörper gegen menschliches Karzinom.
DE69432926T2 (de) Humanes carcinoma-antigen (hca), hca antikörper, hca immunoassays, aufzeichnungsmethoden und therapy
DE3382764T2 (de) Humane-humane hybridomas für neoplasmen.
DE3586440T2 (de) Zur diagnose von menschlichem magen- oder brustkrebs zu verwendender monoklonaler antikoerper.
DE3588043T2 (de) Cytokeratin-tumormarkierer und test zu deren nachweis.
DE3783277T2 (de) Monoklonaler antikoerper gegen humanes lungenkarzinom.
DE3785038T2 (de) Monoklonale antikoerper gegen nicht reduzierte, nicht enzymatisch glykolysierte proteine.
DE69306803T2 (de) Kleinzelliger lungenkarzinom-spezifischer antikörper und antigenen
EP0480440B1 (fr) Anticorps monoclonal contre le mélanome
DE3789781T2 (de) Antigene, Antikörper und Verfahren zur Identifizierung humaner metastatischer Tumoren und Zellinien zur Herstellung dieser Antikörper.
DE3780480T2 (de) Test fuer menschlichen brustkrebs.
DE3587976T2 (de) Monoklonale antikörper und antigene für menschliche lungenkarzinome vom typ der nichtkleinen zellen.
DE3218312C2 (de) Monoklonale Antikörper, Hybridoma-Zellklone, Verfahren zu ihrer Herstellung und ihre Verwendung zur Erkennung von Brustkrebs und maligner Lymphogranulomatose
DE3688638T2 (de) Monoklonale Antikörper für humane Lungenkarzinome des "Nicht-kleine-Zellen"-Typs.
DE69633976T2 (de) Monoklonale antikörper und antigene mit bezug zum menschlichen lungenadenokarzinom und immunoassay-verfahren unter verwendung desselben
EP0443599A2 (fr) Anticorps monoclonaux contre des antigènes associés aux tumeurs, procédé de préparation et utilisation
DE69434024T2 (de) Auf humanen cortikalen thymozyten exprimierte oberflächenproteine und ihre verwendung
DE68926245T2 (de) Nachweis der basismembrankomponenten, diagnose von krebs und sonstigen krankheiten
DE3785795T2 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
DE3490527T (de) Neue monoklonale Antikörper
DE69031225T2 (de) Monoklonaler antikörper zur differenzierung von "squamous cell carcinoma"-antigenen und verfahren zu dessen verwendung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee